Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcoma

✍ Scribed by Elisabetta Tanzi; Alessandra Zappa; Fausta Caramaschi; Antonella Amendola; Donatella Lasagna; Luciana Gatti; Valeria Ascoli; Giovanni Rezza; Alessandro R. Zanetti

• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 127 KB
• Volume: 76
• Category: Article
• ISSN: 0146-6615
• DOI: 10.1002/jmv.20400

✦ Synopsis

Abstract

Previous studies have reported a large variation in the incidence of classical Kaposi's sarcoma across different Districts of the province of Mantua (Northern Italy). To assess whether such differences might be explained by different anti‐HHV8 antibody prevalence, a serological study was conducted in 343 healthy elderly individuals resident in two adjacent Districts, at the highest and the lowest classical Kaposi's sarcoma incidence rate, respectively. Qualitative and quantitative determinations of IgG antibodies against both latent and lytic HHV‐8 antigens were performed by indirect immunofluorescence assay. The assay's sensitivity was studied in 26 patients with classical Kaposi's sarcoma. Overall, anti‐HHV8 antibodies were detected in 25 out of 26 patients (96%), confirming the high sensitivity of this assay. The prevalence of anti‐HHV‐8 antibodies was higher among individuals living in the District had a high incidence of classical Kaposi's sarcoma compared to those living in the District with low incidence (19.4% vs 9.8%, and 15.9% vs 8%; P < 0.05, for latent and lytic antibodies, respectively). Anti‐lytic antibody GMT was higher in people living in the District at high incidence rate compared to those of the other area (328.9 vs. 180.4; P < 0.01). A higher prevalence of HHV‐8 infection was found among persons living in municipalities surrounded by watercourses (OR 2.2, 95% CI: 1.10–4.32). In conclusion, variation in HHV‐8 prevalence appears to explain differences in the incidence rates of classical Kaposi's sarcoma observed in different areas of the province. J. Med. Virol. 76:571–575, 2005. © 2005 Wiley‐Liss, Inc.